% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/FuncStratifiedAnalysis.R
\name{analyzeStratifiedDrugOmic}
\alias{analyzeStratifiedDrugOmic}
\title{Analyze stratified drug-omic associations}
\usage{
analyzeStratifiedDrugOmic(
  dromaset_object,
  stratification_drug,
  strata_quantile = 0.33,
  select_omics_type,
  select_omics,
  select_drugs,
  min_samples = 5,
  ...
)
}
\arguments{
\item{dromaset_object}{A DromaSet or MultiDromaSet object}

\item{stratification_drug}{Drug used to define strata (e.g., "cisplatin")}

\item{strata_quantile}{Quantile threshold for stratification (default: 0.33)}

\item{select_omics_type}{Type of omics data to analyze}

\item{select_omics}{Name of the specific omics feature}

\item{select_drugs}{Name of the target drug for association analysis}

\item{min_samples}{Minimum samples per stratum (default: 5)}

\item{...}{Additional parameters passed to the analysis functions}
}
\value{
List containing stratified analysis results and between-stratum comparisons
}
\description{
Performs drug-omic association analysis within strata defined by
response to a stratification drug. This approach follows the pairing principle
by filtering samples within each pairing operation rather than creating pre-filtered datasets.
Designed for ACC (Activity Area Above the Curve) data where higher values indicate greater sensitivity.
}
\examples{
\dontrun{
# Stratified analysis of ERCC1 expression and bortezomib response
# based on cisplatin sensitivity
result <- analyzeStratifiedDrugOmic(
  dromaset_object = multi_set,
  stratification_drug = "cisplatin",
  strata_quantile = 0.33,
  select_omics_type = "mRNA",
  select_omics = "ERCC1",
  select_drugs = "bortezomib",
  data_type = "CellLine",
  tumor_type = "all"
)
}
}
